Danny Sharp is one of Australia's most experienced corporate advisors, specializing in IPOs, secondary capital raising, M&A transactions, and corporate advisory for ASX-listed companies across various sectors, including medical technology and financial services. They served as a Director at Peter Szabo and Associates from 1997 to 2000 and were a Senior Associate at Abbot Tout Russell Kenney Solicitors from 1991 to 1997. As an Executive Director at Canaccord Genuity Limited from 2012 to 2020, Danny played a pivotal role in expanding the corporate finance team and led significant banking transactions in the life sciences sector. Currently, Danny is an Investment Committee Member at the Baker Heart and Diabetes Institute Foundation and holds non-executive director positions at multiple organizations, including Alcidion Group Ltd and Botanix Pharmaceuticals. They are also a CFA Charter Holder and pursuing a Bachelor's degree in Economics and Laws from Monash University.
This person is not in the org chart
This person is not in any teams